VSH · Vishay Intertechnology, Inc.

Current Thesis

Vishay Intertechnology's order recovery supports a conditional rebound thesis, requiring delivery of Q3 guidance and a weekly close above the broken $35 shelf before a weekly close below $30.56. The original recovery thesis already failed its published price condition: the adjusted close was $30.56 on 2026-08-28, below $35. This narrower recovery test does not reverse that outcome.

The change since the 2026-08-30 note is a higher reference close and another analyst initiation. The shares closed at $33.21 on 2026-09-11; Benzinga reported Truist's initiation with a $42 price target on 2026-09-03. As an inference, the narrative is maturing — coverage expanded after the 2026-08-05 results, but the September close remains beneath the shelf lost in August. A weekly recovery above $35 accompanied by Q3 guidance delivery would challenge that assessment.

Bullish and bearish views on Vishay Intertechnology, Inc.

The model's bull view on Vishay Intertechnology, Inc. (VSH), in brief: Orders support the recovery case. Vishay's 2026-08-05 release reported Q2 book-to-bill, the ratio of orders to billings, of 1.32 and backlog coverage of 6.1 months. These measure orders, not completed future sales. Q2 results Guidance provides a measurable hurdle. On 2026-08-05… The bear view: The broken shelf remains unrecovered. The supplied adjusted-price series records $33.21 on 2026-09-11, still below the prior $35 research shelf. The same snapshot reports a three-month decline of 43.8% and a distance of 48.7% below its $64.70 trailing annual high. Revenue… Both cases follow in full.

Bull Case

• Orders support the recovery case. Vishay's 2026-08-05 release reported Q2 book-to-bill, the ratio of orders to billings, of 1.32 and backlog coverage of 6.1 months. These measure orders, not completed future sales. Q2 results
• Guidance provides a measurable hurdle. On 2026-08-05, management forecast Q3 revenue of $945 million–$975 million and gross margin of 24.0%, plus or minus 50 basis points. Delivery would support the operating recovery; revenue below the range would contradict it. Q2 outlook
• Analyst attention has continued. Benzinga's 2026-09-03 report placed Truist's initiation target at $42. Earlier Benzinga reports dated 2026-08-04 put Raymond James at $40 and Needham at $45. These are attributed analyst expectations, not evidence of subsequent capital inflows.

Bear Case

• The broken shelf remains unrecovered. The supplied adjusted-price series records $33.21 on 2026-09-11, still below the prior $35 research shelf. The same snapshot reports a three-month decline of 43.8% and a distance of 48.7% below its $64.70 trailing annual high.
• Revenue comparisons require reconciliation. The 2026-08-05 release reported revenue under generally accepted accounting principles (GAAP) of $888.6 million versus adjusted revenue of $918.6 million. It attributes the difference to $30.0 million of tariff refunds passed to customers without affecting gross profit. The prior note's headline-miss framing therefore cannot establish weaker demand by itself. Revenue reconciliation
• Equity supply accompanied the advance. StockStory's 2026-06-30 offering report recorded 15 million newly offered shares priced at $50 per share. That documents issuance during the earlier advance; it does not establish whether recipients still hold those shares or whether supply remains at that price.

Setup & Price Structure

The measured change is between the adjusted closes of $30.56 on 2026-08-28 and $33.21 on 2026-09-11. The latter snapshot places the 14-day relative strength index (RSI) at 57.5. These observations establish a rebound between reference dates; the sample is too small to establish a durable base.

For this recovery test, $30.56 names the observed August reference close, while $35 names the previously broken research shelf. Neither is a newly measured moving average. A weekly close above $35 would satisfy the price-repair component; a weekly close below $30.56 would end this recovery thesis.

The dated crowding evidence consists of the 2026-06-30 issuance and analyst initiations on 2026-08-04 and 2026-09-03. Retail participation, fund flows, short interest and distance above a rising moving average are not established by the available evidence. Those gaps preclude a positioning verdict.

Catalyst Calendar (next 30 days)

• 2026-09-24 — Quarterly dividend payment. Vishay's 2026-08-12 filing declared $0.10 per common and Class B share, payable on this date. The 2026-09-10 record date has elapsed. The payment is a scheduled cash distribution, not an operating-demand test. Dividend filing
• ~2026-11-04, estimated — Q3 results. This remains the prior published calendar estimate, not a confirmed company date. It sits outside the next 30 days but is the operating event on which the thesis turns: delivery against the August outlook. As checked on 2026-09-13, Vishay's calendar lists no upcoming events. Company event calendar

What Would Change Our Mind

Loss of the August reference close would show that the rebound has failed: a weekly close below $30.56 invalidates the price thesis. This threshold uses the adjusted close observed on 2026-08-28 and does not imply that a broader support base has been demonstrated.

Operating confirmation requires Q3 revenue within or above the published range and gross margin within or above management's guided band, alongside a weekly close above the previously broken $35 shelf. Q3 revenue below $945 million would independently break the guidance-delivery case. Until those conditions resolve, the failed August price structure supports low conviction.

Correlation Notes

This is a single-company recovery test; the available evidence does not establish confirmation from a wider industrial-power group. The 2026-08-28 coverage cited an AlphaStreet report of a 7.8% session decline alongside semiconductor selling, without a company-specific operational disclosure cited. That observation is insufficient to estimate correlation or establish that sector moves caused Vishay's decline.

A matched return series and repeated dated observations would be needed to substantiate the earlier note's stronger semiconductor-beta claim. The 2026-09-11 price snapshot alone supplies neither.